Yunnan Botanee Bio-Technology Group300957.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 19, 2026, Yunnan Botanee Bio-Technology Group (300957.SZ) trades at a P/E of 24.90x, P/B of 2.23x, P/S of 2.64x, and a dividend yield of 2.00%.
Longitudinal percentile comparison: P/E sits at the 7th percentile over the trailing 10Y window (vs. 12th percentile over 3Y); P/B sits at the 4th percentile over the trailing 10Y window (vs. 7th percentile over 3Y); P/S sits at the 2nd percentile over the trailing 10Y window (vs. 4th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 30th percentile within its industry and the 34th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.00%, ranking at the 85th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 3.0 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Yunnan Botanee Bio-Technology Group operates in the Basic Chemical Engineering sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300957 · SZSE: 300957 · 300957
Want the full picture on whether Yunnan Botanee Bio-Technology Group (300957.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 24.90 | ||||||
| P/B (MRQ) | 2.23 | ||||||
| P/S (TTM) | 2.64 | ||||||
| Dividend Yield | 2.00% | ||||||
| Buyback + Div Yield | 2.00% |